Clinical trial
A Study to Assess Efficacy and Safety of PF-06462700 in Japanese Participants…
NCT04350606 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT04350606 |
|---|---|
| Title | A Study to Assess Efficacy and Safety of PF-06462700 in Japanese Participants With Aplastic Anemia |
| Official title | A MULTICENTER, OPEN-LABEL, SINGLE-ARM STUDY TO ASSESS THE EFFICACY AND SAFETY OF PF-06462700 ADMINISTERED INTRAVENOUSLY AT 40 MG/KG/DAY FOR 4 DAYS IN JAPANESE PARTICIPANTS WITH MODERATE AND ABOVE APLASTIC ANEMIA |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Aplastic Anemia |
| Intervention type | Biological |
| Interventions | PF-06462700 |
| Enrollment | 3 |
| Start date | Jul 25, 2020 |
| Primary completion | Jan 22, 2021 |
| Completion | Apr 19, 2021 |
| First posted | Apr 17, 2020 |
| Last update posted | Apr 27, 2022 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: